Skip to main content
Bindu Kanapuru, MD, Hematology, Falls Church, VA

BinduKanapuruMD

Hematology Falls Church, VA

Myeloproliferative Disorder Hematology-Oncology

Physician

Are you Dr. Kanapuru?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 43 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    3300 Gallows Rd
    Falls Church, VA 22042

Summary

  • Dr. Bindu Kanapuru, MD is a hematologist in Falls Church, Virginia. She is currently licensed to practice medicine in Virginia and Maryland. She is affiliated with Inova Fairfax Medical Campus and Virginia Hospital Center.

Education & Training

  • University of Maryland
    University of MarylandFellowship, Hematology and Medical Oncology, 2008 - 2011
  • MedStar Health/Harbor Hospital
    MedStar Health/Harbor HospitalResidency, Internal Medicine, 2004 - 2007
  • Madras Medical College
    Madras Medical CollegeClass of 1996

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2011 - 2026
  • MD State Medical License
    MD State Medical License 2010 - 2012
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Suzetrigine’s Approval Signals a Shift in Non-Opioid Pain Management
    Suzetrigine’s Approval Signals a Shift in Non-Opioid Pain ManagementFebruary 4th, 2025
  • Cancer Drug’s Withdrawal a Good Thing? “Autopsy” Shows System Works, FDA Says
    Cancer Drug’s Withdrawal a Good Thing? “Autopsy” Shows System Works, FDA SaysJanuary 27th, 2025
  • Criteria for Selecting Who Can Enroll in Multiple Myeloma Clinical Trials May Exclude Patients from Minority Groups
    Criteria for Selecting Who Can Enroll in Multiple Myeloma Clinical Trials May Exclude Patients from Minority GroupsApril 5th, 2023
  • Join now to see all